IMPAX LABORATORIES, INC. v. ZYDUS PHARMACEUTICALS USA, INC. et al
| IMPAX LABORATORIES, INC. |
| ZYDUS PHARMACEUTICALS USA, INC. and CADILA HEALTHCARE LTD. |
| 2:2017cv13476 |
| December 21, 2017 |
| US District Court for the District of New Jersey |
| Newark Office |
| Atlantic |
| Stanley R. Chesler |
| Cathy L. Waldor |
| Patent - Abbreviated New Drug Application |
| 15 U.S.C. ยง 1126 |
| None |
Follow case documents by RSS
Available Case Documents
The following documents for this case are available for you to view or download:
| Document Text |
|---|
Filing
211
OPINION and ORDER denying 196 Defendants' Motion in Limine; denying 198 Plaintiff's Motion in Limine. etc. Signed by Judge Stanley R. Chesler on 3/24/2020. (dam, )
|
|
Filing
145
OPINION AND ORDER; The Court concludes that Plaintiff is correct and that the phrase, "a controlled release oral solid formulation of levodopa," has its ordinary meaning.. Signed by Judge Stanley R. Chesler on 7/25/2019. (ld, )
|
|
Filing
108
ORDER granting 104 MOTION to Redact and Seal Transcript/Digital Recording re: 89 Transcript. Signed by Magistrate Judge Cathy L. Waldor on 12/6/2018. (gl, )
|
|
Filing
102
OPINION. Signed by Judge Stanley R. Chesler on 11/29/2018. (dam, )
|
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the New Jersey District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
